[^1]
PDHA2 Structure
[^2]
[^3]
[^4]
Gene: [PDHA2](/genes/pdha2)
[^5]
UniProt: [P11177](https://www.uniprot.org/uniprot/P11177)
[^6]
PDB ID: 3EXD, 1NI4
[^7]
Molecular Weight: ~43 kDa
[^8]
Subcellular Localization: Mitochondrial matrix
Protein Family: Pyruvate dehydrogenase complex E1 alpha subunit family
PDHA2 (Pyruvate Dehydrogenase E1 Component Subunit Alpha 2) is the testis/spermatogen-specific isoform of the pyruvate dehydrogenase E1 alpha subunit. While primarily expressed in testis, PDHA2 has been detected in brain tissue and has been implicated in neurodegenerative diseases. The pyruvate dehydrogenase complex (PDC) is essential for converting pyruvate to acetyl-CoA, linking glycolysis to the citric acid cycle and oxidative phosphorylation.
PDHA2 forms a heterotetrameric structure:
- N-terminal Region: Contains the binding site for the lipoyl cofactor
- C-terminal Catalytic Domain: Contains the thiamine pyrophosphate (TPP) binding site
- Phosphorylation Sites: S293, S300, and S232 (regulatory serine residues)
The protein forms an α₂β₂ heterotetramer with PDHB (E1 beta subunit). PDHA2 has three serine phosphorylation sites that regulate activity: phosphorylation inactivates the enzyme, while dephosphorylation activates it. The structure reveals the TPP cofactor binding pocket and the dimer interface.
While PDHA2 is primarily a testis-specific isoform, it has important roles in neurons:
- Catalyzes pyruvate oxidation in mitochondria
- Provides acetyl-CoA for the citric acid cycle
- Essential for neuronal ATP production
- Links glycolysis to oxidative phosphorylation
- Responds to cellular energy demands
- Regulated by phosphorylation/dephosphorylation
- Controlled by pyruvate dehydrogenase kinase (PDK) and phosphatase (PDP)
- Integrates metabolic signals with neuronal activity
- Affects NADH/FADH₂ production
- Modulates reactive oxygen species (ROS) generation
- Important for maintaining redox balance
- Links metabolism to antioxidant responses
- PDH activity is reduced in AD brains
- Impaired glucose metabolism is an early feature of AD
- PDHA2 may contribute to brain energy deficits
- Links to mitochondrial dysfunction in AD
- Altered PDH activity in PD models
- Energy metabolism deficits in dopaminergic neurons
- May contribute to vulnerability of substantia nigra neurons
- Connected to mitochondrial complex I deficiency
- Mutations in PDHA1 (the somatic isoform) cause Leigh syndrome
- Characterized by severe encephalopathy and metabolic crisis
- Similar mechanisms may involve PDHA2
- Highlights importance of PDH in brain function
- Diabetes and metabolic syndrome affect brain function
- PDH activity linked to cognitive decline
- May contribute to vascular dementia
- Dichloroacetate (DCA): Inhibits PDK, activating PDH
- Being studied for various neurological conditions
- Ketogenic diet to bypass PDH
- Glucose metabolism optimization
- Mitochondrial-targeted therapies
- Gene therapy approaches
- Small molecule PDH activators
- Metabolic modulation strategies
- Systemic vs. CNS-specific effects
- Balancing glucose and ketone metabolism
- Understanding isoform-specific roles
-
Patel et al. (2013). Pyruvate dehydrogenase complex: Biochemical regulation and functions in cellular metabolism. Current Drug Targets, 14(4), 490-501.
-
Huang et al. (2018). Pyruvate dehydrogenase complex in Alzheimer's disease: Regulation and therapeutic targeting. Neurochemical Research, 43(10), 1879-1888.
-
Schiff et al. (2011). Pyruvate dehydrogenase deficiency and the molecular basis of the lactic acidoses. Molecular Genetics and Metabolism, 104(1-2), 11-18.
-
Gibson et al. (2003). Pyruvate dehydrogenase deficiency in the brain. Neurochemistry International, 43(4-5), 415-419.